The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson’s disease
Open accessAbstract
SEE SCHRAG AND POLITIS DOI101093/AWW190 FOR A SCIENTIFIC COMMENTARY ON THIS ARTICLE: Apathy, which can occur separately or in combination with depression and anxiety, is one of the most frequently encountered neuropsychiatric symptoms in Parkinson's disease. Pathophysiological evidence suggests that parkinsonian apathy is primarily due to a mesolimbic dopaminergic denervation, but the role of the serotonergic alteration has never been examined, despite its well-known involvement in the pathogenesis of depression and anxiety. To fill this gap, we address here the pure model of de novo Parkinson's disease, without the confounding effects of antiparkinsonian treatment. Fifteen apathetic (Lille Apathy Rating Scale scores ≥ -21) and 15 non-apathetic (-36 ≤ Lille Apathy Rating Scale scores ≤ -22) drug-naïve de novo parkinsonian patients were enrolled in the present study and underwent detailed clinical assessment and positron emission tomography imaging, using both dopaminergic [(11)C-N-(3-iodoprop-2E-enyl)-2-beta-carbomethoxy-3-beta-(4-methylphenyl)-nortropane (PE2I)] (n = 29) and serotonergic [(11)C-N,N-dimethyl-2-(-2-amino-4-cyanophenylthio)-benzylamine (DASB)] (n = 27) presynaptic transporter radioligands. Apathetic parkinsonian patients presented higher depression (P = 0.0004) and anxiety (P = 0.004) scores - as assessed using the Beck Depression Inventory and the part B of the State-Trait Anxiety Inventory, respectively - compared to the non-apathetic ones - who were not different from the age-matched healthy subjects (n = 15). Relative to the controls, the non-apathetic parkinsonian patients mainly showed dopaminergic denervation (n = 14) within the right caudate nucleus, bilateral putamen, thalamus and pallidum, while serotonergic innervation (n = 15) was fairly preserved. Apathetic parkinsonian patients exhibited, compared to controls, combined and widespread dopaminergic (n = 15) and serotonergic (n = 12) degeneration within the bilateral caudate nuclei, putamen, ventral striatum, pallidum and thalamus, but also a specific bilateral dopaminergic disruption within the substantia nigra-ventral tegmental area complex, as well as a specific serotonergic alteration within the insula, the orbitofrontal and the subgenual anterior cingulate cortices. When comparing the two parkinsonian groups, the apathetic patients mainly displayed greater serotonergic alteration in the ventral striatum, the dorsal and the subgenual parts of the anterior cingulate cortices, bilaterally, as well as in the right-sided caudate nucleus and the right-sided orbitofrontal cortex. Regression analyses also revealed that the severity of apathy was moreover mainly related to specific serotonergic lesions within the right-sided anterior caudate nucleus and the orbitofrontal cortex, while the degree of both depression and anxiety was primarily linked to serotonergic disruption within the bilateral subgenual parts and/or the right dorsal part of the anterior cingulate cortex, without prominent role of the dopaminergic degeneration in the pathogenesis of these three non-motor signs. Altogether, these findings highlight a prominent role of the serotonergic degeneration in the expression of the neuropsychiatric symptoms occurring at the onset of Parkinson's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An inventory for measuring clinical anxiety: Psychometric properties.
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.56.6.893 · Cited by 14,407
Goetz, C. G., Tilley, B. C., Shaftman, S. R., Stebbins, G. T., Fahn, S., Martinez‐Martin, P., Poewe, W., Sampaio, C., Stern, M. B., Dodel, R., et al. (2008) · Movement Disorders · doi:10.1002/mds.22340 · Cited by 7,536
The FAB: A frontal assessment battery at bedside
Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000) · Neurology · doi:10.1212/wnl.55.11.1621 · Cited by 3,913
The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
Gibb, W. R., & Lees, A. J. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.745 · Cited by 3,481
Simplified Reference Tissue Model for PET Receptor Studies
Lammertsma, A. A., & Hume, S. P. (1996) · NeuroImage · doi:10.1006/nimg.1996.0066 · Cited by 2,021
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
Chaudhuri, K. R., & Schapira, A. H. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70068-7 · Cited by 1,738
Barone, P., Antonini, A., Colosimo, C., Marconi, R., Morgante, L., Avarello, T. P., Bottacchi, E., Cannas, A., Ceravolo, G., Ceravolo, R., et al. (2009) · Movement Disorders · doi:10.1002/mds.22643 · Cited by 1,445
Development and validation of the Neuropathic Pain Symptom Inventory
Bouhassira, D., Attal, N., Fermanian, J., Alchaar, H., Gautron, M., Masquelier, E., Rostaing, S., Lanteri-Minet, M., Collin, E., Grisart, J., et al. (2004) · Pain · doi:10.1016/j.pain.2003.12.024 · Cited by 1,329
Hammers, A., Allom, R., Koepp, M. J., Free, S. L., Myers, R., Lemieux, L., Mitchell, T. N., Brooks, D. J., & Duncan, J. S. (2003) · Human Brain Mapping · doi:10.1002/hbm.10123 · Cited by 1,286
Parametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model
Gunn, R. N., Lammertsma, A. A., Hume, S. P., & Cunningham, V. J. (1997) · NeuroImage · doi:10.1006/nimg.1997.0303 · Cited by 1,084
Remy, P., Doder, M., Lees, A., Turjanski, N., & Brooks, D. (2005) · Brain · doi:10.1093/brain/awh445 · Cited by 1,040
Multimodal Image Coregistration and Partitioning—A Unified Framework
Ashburner, J., & Friston, K. (1997) · NeuroImage · doi:10.1006/nimg.1997.0290 · Cited by 927
Prediagnostic presentations of Parkinson’s disease in primary care: A case-control study
Schrag, A., Horsfall, L., Walters, K., Noyce, A., & Petersen, I. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70287-x · Cited by 674
Brooks, D. J., Ibanez, V., Sawle, G. V., Quinn, N., Lees, A. J., Mathias, C. J., Bannister, R., Marsden, C. D., & Frackowiak, R. S. J. (1990) · Annals of Neurology · doi:10.1002/ana.410280412 · Cited by 626
Subcallosal Cingulate Deep Brain Stimulation for Treatment-Resistant Unipolar and Bipolar Depression
Holtzheimer, P. E. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1456 · Cited by 608
Barone, P., Poewe, W., Albrecht, S., Debieuvre, C., Massey, D., Rascol, O., Tolosa, E., & Weintraub, D. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70106-x · Cited by 562
Neuropsychiatric symptoms in Parkinson's disease
Aarsland, D., Marsh, L., & Schrag, A. (2009) · Movement Disorders · doi:10.1002/mds.22589 · Cited by 557
Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment
Pagonabarraga, J., Kulisevsky, J., Strafella, A. P., & Krack, P. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00019-8 · Cited by 549
Self-citationThobois, S., Ardouin, C., Lhommee, E., Klinger, H., Lagrange, C., Xie, J., Fraix, V., Coelho Braga, M. C., Hassani, R., Kistner, A., et al. (2010) · Brain · doi:10.1093/brain/awq032 · Cited by 516
Self-citationSockeel, P. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.075929 · Cited by 513
Physical and clinical performance of the mCT time-of-flight PET/CT scanner
Jakoby, B. W., Bercier, Y., Conti, M., Casey, M. E., Bendriem, B., & Townsend, D. W. (2011) · Physics in Medicine and Biology · doi:10.1088/0031-9155/56/8/004 · Cited by 492
Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease
Kish, S. J., Tong, J., Hornykiewicz, O., Rajput, A., Chang, L.-J., Guttman, M., & Furukawa, Y. (2007) · Brain · doi:10.1093/brain/awm239 · Cited by 375
Brown, R. G., Dittner, A., Findley, L., & Wessely, S. C. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.07.007 · Cited by 361
Automatic segmentation of brain MRIs of 2-year-olds into 83 regions of interest
Gousias, I. S., Rueckert, D., Heckemann, R. A., Dyet, L. E., Boardman, J. P., Edwards, A. D., & Hammers, A. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2007.11.034 · Cited by 355
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
Richard, I. H., McDermott, M. P., Kurlan, R., Lyness, J. M., Como, P. G., Pearson, N., Factor, S. A., Juncos, J., Serrano Ramos, C., Brodsky, M., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182516244 · Cited by 338
Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction
Pavese, N., Metta, V., Bose, S. K., Chaudhuri, K. R., & Brooks, D. J. (2010) · Brain · doi:10.1093/brain/awq268 · Cited by 333
Clinical spectrum of impulse control disorders in Parkinson’s disease
Weintraub, D., David, A. S., Evans, A. H., Grant, J. E., & Stacy, M. (2015) · Movement Disorders · doi:10.1002/mds.26016 · Cited by 311
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease
Weintraub, D., Simuni, T., Caspell‐Garcia, C., Coffey, C., Lasch, S., Siderowf, A., Aarsland, D., Barone, P., Burn, D., Chahine, L. M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26170 · Cited by 305
Tremor in Parkinson’s disease and serotonergic dysfunction: An 11 C-WAY 100635 PET study
Doder, M., Rabiner, E. A., Turjanski, N., Lees, A. J., & Brooks, D. J. (2003) · Neurology · doi:10.1212/01.wnl.0000031424.51127.2b · Cited by 302
Weintraub, D. A., Newberg, A. B., Cary, M. S., Siderowf, A. D., Moberg, P. J., Kleiner‐Fisman, G., Duda, J. E., Stern, M. B., Mozley, D. P., & Katz, I. R. (2005) · PubMed · Cited by 293
Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil
Thobois, S., Lhommée, E., Klinger, H., Ardouin, C., Schmitt, E., Bichon, A., Kistner, A., Castrioto, A., Xie, J., Fraix, V., et al. (2013) · Brain · doi:10.1093/brain/awt067 · Cited by 274
Self-citationStaging of serotonergic dysfunction in Parkinson's Disease: An in vivo 11C-DASB PET study
Politis, M., Wu, K., Loane, C., Kiferle, L., Molloy, S., Brooks, D. J., & Piccini, P. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.028 · Cited by 242
Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures
Politis, M., Wu, K., Loane, C., Turkheimer, F. E., Molloy, S., Brooks, D. J., & Piccini, P. (2010) · Neurology · doi:10.1212/wnl.0b013e3181feb2ab · Cited by 224
Clinical correlates of raphe serotonergic dysfunction in early Parkinson’s disease
Qamhawi, Z., Towey, D., Shah, B., Pagano, G., Seibyl, J., Marek, K., Borghammer, P., Brooks, D. J., & Pavese, N. (2015) · Brain · doi:10.1093/brain/awv215 · Cited by 218
Devos, D., Moreau, C., Maltete, D., Lefaucheur, R., Kreisler, A., Eusebio, A., Defer, G., Ouk, T., Azulay, J.-P., Krystkowiak, P., et al. (2014) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-306439 · Cited by 199
The Mattis Dementia Rating Scale: Normative data from 1,001 healthy volunteers
Schmidt, R., Freidl, W., Fazekas, F., Reinhart, B., Grieshofer, P., Koch, M., Eber, B., Schumacher, M., Polmin, K., & Lechner, H. (1994) · Neurology · doi:10.1212/wnl.44.5.964 · Cited by 186
Regional distribution of serotonin transporter protein in postmortem human brain
Kish, S. J., Furukawa, Y., Chang, L.-J., Tong, J., Ginovart, N., Wilson, A., Houle, S., & Meyer, J. H. (2005) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2004.10.001 · Cited by 179
The serotonin transporter in psychiatric disorders: insights from PET imaging
Spies, M., Knudsen, G. M., Lanzenberger, R., & Kasper, S. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00232-1 · Cited by 177
Boileau, I., Warsh, J. J., Guttman, M., Saint‐Cyr, J. A., McCluskey, T., Rusjan, P., Houle, S., Wilson, A. A., Meyer, J. H., & Kish, S. J. (2008) · Movement Disorders · doi:10.1002/mds.22212 · Cited by 171
Pharmacotherapy of neuropathic pain: which drugs, which treatment algorithms?
Attal, N., & Bouhassira, D. (2015) · Pain · doi:10.1097/01.j.pain.0000460358.01998.15 · Cited by 167
Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson's disease
Ballanger, B., Klinger, H., Eche, J., Lerond, J., Vallet, A., Bars, D. L., Tremblay, L., Sgambato, V., Broussolle, E., & Thobois, S. (2011) · Movement Disorders · doi:10.1002/mds.23895 · Cited by 163
Self-citationDe Deurwaerdère, P., & Di Giovanni, G. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.03.004 · Cited by 163
Skidmore, F. M., Yang, M., Baxter, L., von Deneen, K., Collingwood, J., He, G., Tandon, R., Korenkevych, D., Savenkov, A., Heilman, K. M., et al. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2011.07.012 · Cited by 158
Positron Emission Tomography of Striatal Serotonin Transporters in Parkinson Disease
Kerényi, L., Ricaurte, G. A., Schretlen, D. J., McCann, U. D., Varga, J., Mathews, W. B., Ravert, H. T., Dannals, R. F., Hilton, J., Wong, D. F., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.9.1223 · Cited by 154
Évaluation des troubles comportementaux hyper- et hypodopaminergiques dans la maladie de Parkinson
Ardouin, C., Chéreau, I., Llorca, P., Lhommée, E., Durif, F., Pollak, P., & Krack, P. (2009) · Revue Neurologique · doi:10.1016/j.neurol.2009.06.003 · Cited by 152
Self-citationCourse of psychiatric symptoms and global cognition in early Parkinson disease
de la Riva, P., Smith, K. M., Xie, S. X., & Weintraub, D. A. (2014) · Neurology · doi:10.1212/wnl.0000000000000801 · Cited by 139
Hall, H., Halldin, C., Guilloteau, D., Chalon, S., Emond, P., Besnard, J., Farde, L., & Sedvall, G. (1999) · NeuroImage · doi:10.1006/nimg.1998.0366 · Cited by 137
Spared Caudal Brainstem SERT Binding in Early Parkinson's Disease
Albin, R. L., Koeppe, R. A., Bohnen, N. I., Wernette, K., Kilbourn, M., & Frey, K. A. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600599 · Cited by 134
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients
Santangelo, G., Vitale, C., Picillo, M., Cuoco, S., Moccia, M., Pezzella, D., Erro, R., Longo, K., Vicidomini, C., Pellecchia, M. T., et al. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.02.015 · Cited by 124
Boileau, I., Guttman, M., Rusjan, P., Adams, J. R., Houle, S., Tong, J., Hornykiewicz, O., Furukawa, Y., Wilson, A. A., Kapur, S., et al. (2009) · Brain · doi:10.1093/brain/awn337 · Cited by 112
Emotional manifestations of PD: Neurobiological basis
Castrioto, A., Thobois, S., Carnicella, S., Maillet, A., & Krack, P. (2016) · Movement Disorders · doi:10.1002/mds.26587 · Cited by 105
Self-citationApathy in untreated early‐stage Parkinson disease: Relationship with other non‐motor symptoms
Dujardin, K., Langlois, C., Plomhause, L., Carette, A., Delliaux, M., Duhamel, A., & Defebvre, L. (2014) · Movement Disorders · doi:10.1002/mds.26058 · Cited by 94
New insight into the therapeutic role of the serotonergic system in Parkinson's disease
Ohno, Y., Shimizu, S., Tokudome, K., Kunisawa, N., & Sasa, M. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.005 · Cited by 86
Strecker, K., Wegner, F., Hesse, S., Becker, G., Patt, M., Meyer, P., Lobsien, D., Schwarz, J., & Sabri, O. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5666-5 · Cited by 85
Flik, G., Folgering, J. H. A., Cremers, T. I. H. F., Westerink, B. H. C., & Dremencov, E. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0536-3 · Cited by 77
A volumetric MRI study of limbic, associative and sensorimotor striatal subregions in schizophrenia
Levitt, J. J., Rosow, L. K., Nestor, P. G., Pelavin, P. E., Swisher, T., McCarley, R. W., & Shenton, M. E. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2012.08.032 · Cited by 36
Joutsa, J., Johansson, J. J., Seppänen, M., Noponen, T., & Kaasinen, V. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.153734 · Cited by 32
Beucke, J. C., Plotkin, M., Winter, C., Endraß, T., Amthauer, H., Juckel, G., & Kupsch, A. R. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03274.x · Cited by 15
Cited by
Diagnosis and Treatment of Parkinson Disease: A Review
Armstrong, M. J., & Okun, M. S. (2020) · JAMA · doi:10.1001/jama.2019.22360 · Cited by 2,924
Parkinson disease-associated cognitive impairment
Aarsland, D., Batzu, L., Halliday, G. M., Geurtsen, G. J., Ballard, C., Ray Chaudhuri, K., & Weintraub, D. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00280-3 · Cited by 1,371
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193
Neuroscience of apathy and anhedonia: a transdiagnostic approach
Husain, M., & Roiser, J. P. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0029-9 · Cited by 640
Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update
Voon, V., Napier, T. C., Frank, M. J., Sgambato-Faure, V., Grace, A. A., Rodriguez-Oroz, M., Obeso, J., Bezard, E., & Fernagut, P.-O. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30004-2 · Cited by 359
Self-citation
Metadata
- Authors
- Maillet, A., Krack, P., Lhommée, E., Météreau, E., Klinger, H., Favre, E., Le Bars, D., Schmitt, E., Bichon, A., Pelissier, P., Fraix, V., Castrioto, A., Sgambato-Faure, V., Broussolle, E., Tremblay, L., & Thobois, S.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-08-17
- Volume
- 139
- Issue
- 9
- Pages
- 2486-2502
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2513927570
- Cited by
- 282
- References
- 58
- FWCI
- 14.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.